Medivation Announces Participation at Upcoming Investor Conference
SAN FRANCISCO, CA -- (Marketwired) -- 01/31/14 -- Medivation, Inc.
(NASDAQ: MDVN) today announced that it will present at the following
-- David Hung, M.D., president and chief executive officer, will present
at the Leerink Global Healthcare Conference on Wednesday, February 12
at 11:30am ET at the Waldorf Astoria Hotel, New York, NY.
Individuals may access the live audio webcast by visiting:
http://investors.medivation.com/events.cfm. A replay of the webcast
will be available on the Company's website for 30 days following the
Medivation, Inc. is a biopharmaceutical company
focused on the rapid development of novel therapies to treat serious
diseases for which there are limited treatment options. Medivation
aims to transform the treatment of these diseases and offer hope to
critically ill patients and their families. For more information,
please visit us at www.medivation.com.
Chief Business & Financial Officer
Sr. Director, Investor Relations
Press spacebar to pause and continue. Press esc to stop.